Sign In
Buy EVGN
$0.471
-0.0184 (-3.76%)
At Close: Jul 31, 2026
EverGen Infrastructure Reports Q4 & Year End 2025 Results
07:46pm, Wednesday, 29'th Apr 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), reported audited financial results as at and for Q4 2025 af
Evogene (NASDAQ:EVGN) Stock Crosses Below 200 Day Moving Average – Here’s Why
03:25am, Friday, 17'th Apr 2026
Evogene Ltd. (NASDAQ: EVGN - Get Free Report) shares crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $1.04 and traded as low as $0.78. Ev
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
04:01pm, Thursday, 02'nd Apr 2026
REHOVOT, Israel, April 2, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN)(TASE: EVGN) (the "Company", "Evogene"), a pioneering company in computational chemistry, specializing in the generative desig
Today, castor oil is a premium sustainable industrial feedstock for bio-based products REHOVOT, Israel, March 31, 2026 /PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), a developer of high-yield castor s
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
09:00am, Monday, 09'th Mar 2026
Conference will be held at Lisbon, Portugal - March 23–25, 2026 REHOVOT, Israel, March 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemis
Evogene Q4 Earnings Call Highlights
04:48am, Saturday, 07'th Mar 2026
Evogene (NASDAQ: EVGN) executives used the company's fourth-quarter and full-year 2025 results call to outline a strategic transformation that narrowed its technology and market focus, while the finan
Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript
04:46pm, Thursday, 05'th Mar 2026
Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
07:00am, Thursday, 05'th Mar 2026
Conference call and webcast: today, March 05, 2026, 9:00 AM ET REHOVOT, Israel, March 5, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemi
Evogene Releases CEO Letter to Shareholders
08:00am, Wednesday, 25'th Feb 2026
Updating on Strategic Progress and Outlook REHOVOT, Israel, Feb. 25, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in the ge
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release
08:00am, Thursday, 19'th Feb 2026
Zoom conference call scheduled for March 5, 2026, 9:00 AM ET REHOVOT, Israel, Feb. 19, 2026 /PRNewswire/ -- Evogene Ltd . (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry,
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
08:00am, Tuesday, 17'th Feb 2026
Aiming to introduce a new therapeutic strategy for overcoming chemotherapy resistance in lung cancer due to increased expression of cellular pathways REHOVOT, Israel, Feb. 17, 2026 /PRNewswire/ -- Evo
The collaboration is supported by a pan-European EUREKA grant, with participation of the Weizmann Institute of Science REHOVOT, Israel and MUNICH, Germany, Feb. 11, 2026 /PRNewswire/ -- Evogene Ltd.
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds
01:20pm, Tuesday, 10'th Feb 2026
REHOVOT, Israel and BOSTON, Feb. 10, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) ("Evogene" or the "Company"), a pioneering computational chemistry company, specializing in the gene
Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™
08:00am, Tuesday, 10'th Feb 2026
The new collaboration is expected to accelerate, scale and advance small-molecule discovery and optimization for pharmaceutical and agricultural products REHOVOT, Israel, Feb. 10, 2026 /PRNewswire/ --
Evogene Appoints Prof. John Irwin and Prof.
08:00am, Monday, 09'th Feb 2026
Appointments Strengthen Scientific Leadership and Support the Acceleration of ChemPass AI™ for Drug and Ag-Chemical Discovery REHOVOT, Israel, Feb. 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVG
